TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)

Migration, Crosslink

📖

TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tnfaip6

📖 Wiki Page

gene1900 wordssynced 2026-04-02

TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)

Overview

TNFAIP6 (TNF Alpha Induced Protein 6), also known as TSG-6 (Tumor Necrosis Factor-Stimulated Gene 6 protein), is a secreted glycoprotein that plays crucial roles in cell adhesion, inflammatory responses, and extracellular matrix organization [1]. Discovered as a TNF-α-inducible gene in fibroblasts, TSG-6 has emerged as an important mediator of inflammation and tissue remodeling in various physiological and pathological contexts.

The TNFAIP6 gene encodes a 354-amino acid precursor protein that undergoes proteolytic processing to generate a mature secreted protein of approximately 35 kDa [2]. This protein is characterized by its unique ability to bind hyaluronan (HA) and other glycosaminoglycans, making it a key regulator of the extracellular matrix and cell-matrix interactions.

Located on chromosome 2p23.3, the TNFAIP6 gene is expressed in a variety of tissues and cell types, with particularly high expression in inflamed tissues, activated leukocytes, and stromal cells [3]. In the central nervous system, TNFAIP6/TSG-6 is expressed in astrocytes, microglia, and neurons, where it modulates neuroinflammatory responses and contributes to neural repair processes.

...

TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)

Overview

TNFAIP6 (TNF Alpha Induced Protein 6), also known as TSG-6 (Tumor Necrosis Factor-Stimulated Gene 6 protein), is a secreted glycoprotein that plays crucial roles in cell adhesion, inflammatory responses, and extracellular matrix organization [1]. Discovered as a TNF-α-inducible gene in fibroblasts, TSG-6 has emerged as an important mediator of inflammation and tissue remodeling in various physiological and pathological contexts.

The TNFAIP6 gene encodes a 354-amino acid precursor protein that undergoes proteolytic processing to generate a mature secreted protein of approximately 35 kDa [2]. This protein is characterized by its unique ability to bind hyaluronan (HA) and other glycosaminoglycans, making it a key regulator of the extracellular matrix and cell-matrix interactions.

Located on chromosome 2p23.3, the TNFAIP6 gene is expressed in a variety of tissues and cell types, with particularly high expression in inflamed tissues, activated leukocytes, and stromal cells [3]. In the central nervous system, TNFAIP6/TSG-6 is expressed in astrocytes, microglia, and neurons, where it modulates neuroinflammatory responses and contributes to neural repair processes.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TNF Alpha Induced Protein 6</th></tr>
<tr><td>Gene Symbol</td><td>TNFAIP6</td></tr>
<tr><td>Full Name</td><td>TNF alpha induced protein 6 (TSG-6)</td></tr>
<tr><td>Chromosome</td><td>2p23.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[7132](https://www.ncbi.nlm.nih.gov/gene/7132)</td></tr>
<tr><td>OMIM</td><td>191163</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000123607</td></tr>
<tr><td>UniProt ID</td><td>[P20742](https://www.uniprot.org/uniprot/P20742)</td></tr>
<tr><td>Protein Class</td><td>Secreted glycoprotein, Hyaluronan-binding protein</td>
<tr><td>Aliases</td><td>TSG-6, Hyaluronan-binding protein 2</td></tr>
<tr><td>Associated Diseases</td><td>Alzheimer's Disease, Neuroinflammation, Multiple Sclerosis, Brain injury</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The TNFAIP6 gene spans approximately 6 kb on chromosome 2p23.3 and consists of 7 exons [4]. The gene promoter contains multiple responsive elements, including:

NF-κB binding sites: Mediate TNF-α induced expression
AP-1 sites: Respond to phorbol esters and growth factors
STAT elements: Mediate interferon responses
Glucocorticoid response elements: Modulate anti-inflammatory effects

Protein Domain Structure

TSG-6 possesses a modular architecture with distinct functional domains:

N-terminus (1-80 aa) Link module (81-250 aa) C-terminus (251-354 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ Signal peptide │ │ Link module │ │ CUB domain │
│ (1-23 aa) │ │ (hyaluronan │ │ (complement │
│ │ │ binding) │ │ proteinases) │
│ Propeptide │ │ │ │ │
│ (24-80 aa) │ │ Serum albumin │ │ Protein-protein │
│ │ │ motif │ │ interactions │
└────────────────────┘ └──────────────────┘ └────────────────────┘

Signal Peptide — The N-terminal 23-amino acid signal peptide directs TSG-6 to the secretory pathway. This allows the protein to be secreted and act extracellularly.

Link Module — The central Link module (amino acids 81-250) is the key functional domain responsible for hyaluronan binding [5]. This domain shares homology with the hyaluronan-binding regions of other proteins like CD44 and aggrecan.

CUB Domain — The C-terminal domain (amino acids 251-354) is structurally related to complement proteins (CUB domain) and mediates protein-protein interactions.

Post-Translational Processing

TSG-6 undergoes specific post-translational modifications [6]:

Signal peptide cleavage: Generates pro-TSG-6
Proteolytic processing: Remove N-terminal propeptide
Disulfide bond formation: Stabilizes protein structure
Glycosylation: Adds carbohydrate moieties

Biological Function

Hyaluronan Binding and ECM Organization

TSG-6's primary function is binding hyaluronan, a major component of the extracellular matrix [7]:

Hyaluronan cross-linking: Forms stable HA-rich matrices
Matrix stabilization: Creates protective barriers
Cell migration: Modulates cell movement through tissues
Tissue hydration: Maintains tissue water balance

This hyaluronan-binding function is critical for tissue remodeling and repair processes.

Anti-Inflammatory Properties

TSG-6 exerts potent anti-inflammatory effects through multiple mechanisms [8]:

Hyaluronan organization: Forms anti-inflammatory HA matrices

Protease inhibition: Inhibits serine proteases like plasmin

Cell migration blockade: Prevents inflammatory cell infiltration

Cytokine modulation: Reduces pro-inflammatory cytokine production

These anti-inflammatory properties make TSG-6 important in both acute and chronic inflammatory conditions.

Cell Adhesion Modulation

TSG-6 modulates cell-cell and cell-matrix adhesion [9]:

Integrin interactions: Modulates integrin-mediated adhesion
CD44 binding: Cooperates with CD44 for HA binding
Cell migration: Controls inflammatory cell trafficking
Wound healing: Promotes tissue repair

The balance between promoting and inhibiting cell adhesion depends on the cellular context.

Immune Cell Regulation

TSG-6 affects various immune cell functions [10]:

Mast cells: TSG-6 is acquired by mast cells and modulates their function
Neutrophils: Inhibits neutrophil infiltration
Monocytes/Macrophages: Modulates macrophage activation
T cells: Affects T cell proliferation and activation

Expression Pattern

Tissue Distribution

TNFAIP6 exhibits inducible expression across multiple tissues [11]:

| Tissue | Expression Level | Regulation |
|--------|-----------------|------------|
| Brain | Moderate | Strongly inducible |
| Lung | High | Inducible by inflammation |
| Heart | Low-Moderate | Constitutive + inducible |
| Skin | High | Inducible |
| Joint tissue | Very high | Inflammatory |
| Eye | Moderate | Inducible |

Cellular Localization in the Brain

Within the central nervous system, TSG-6 expression is dynamically regulated [12]:

Astrocytes — Primary source of TSG-6 in the brain. Reactive astrocytes upregulate TNFAIP6 in response to inflammatory stimuli.

Neurons — Lower expression, but neurons can produce TSG-6 under certain conditions.

Microglia — Activated microglia express TSG-6, contributing to anti-inflammatory responses.

Endothelial cells — Vascular endothelial cells produce TSG-6, affecting blood-brain barrier function.

Regulatory Mechanisms

TSG-6 expression is tightly controlled at multiple levels [13]:

Transcriptional: NF-κB, AP-1, and other transcription factors
Post-transcriptional: mRNA stability control
Post-translational: Proteolytic processing and secretion
Cell type-specific: Different cell types show distinct regulation

Role in Neurodegenerative Diseases

Alzheimer's Disease

TSG-6 dysregulation contributes to Alzheimer's disease pathogenesis [14]:

Neuroinflammation:

Altered TSG-6 expression in AD brain tissue
May modulate amyloid-β induced inflammation
HA matrices regulated by TSG-6 affect plaque formation

Therapeutic Implications:

Enhancing TSG-6 may reduce neuroinflammation
HA/TSG-6 complexes being explored as therapeutic agents
Gene therapy approaches under investigation

Multiple Sclerosis

In demyelinating diseases [15]:

TSG-6 is upregulated in MS lesions
May protect against demyelination
Therapeutic potential in animal models
Biomarker potential for disease activity

Brain Injury and Stroke

TSG-6 plays protective roles in acute brain injury [16]:

Neuroprotection:

Upregulated after traumatic brain injury
Reduces inflammatory damage
Promotes tissue repair
Improves functional recovery in models

Therapeutic Implications:

Recombinant TSG-6 being developed for stroke treatment
Gene therapy approaches
Combination with other neuroprotective factors

Neuroinflammation

In chronic neuroinflammatory conditions [17]:

TSG-6 acts as an anti-inflammatory mediator
May be therapeutic in conditions like encephalitis
Modulates microglial activation
Could be targeted for therapeutic benefit

Interaction Network

Protein Interactions

TSG-6 interacts with multiple protein partners [18]:

Direct Partners:

Hyaluronan: Primary binding target
CD44: HA receptor, cooperates for signaling
Inter-α-trypsin inhibitor: Forms complexes in plasma
Plasminogen: TSG-6 inhibits plasmin activity

Functional Partners:

Matrix metalloproteinases: TIMP-like activity
Integrins: Modulates integrin signaling
Toll-like receptors: May affect TLR signaling

Signaling Pathways

TSG-6 interfaces with multiple signaling cascades [19]:

HA-CD44 signaling: Controls cell survival and proliferation

PI3K/Akt pathway: Mediates anti-apoptotic effects

NF-κB signaling: Modulates inflammatory responses

ERK/MAPK pathway: Affects cell proliferation

TGF-β signaling: Cooperates with growth factors

Animal Models

Knockout Studies

Tnfaip6-deficient mice have provided important insights [20]:

Viable and fertile: No major developmental defects
Enhanced inflammation: Increased inflammatory responses
Accelerated damage: Exacerbated tissue injury
Fertility issues: Female infertility in some backgrounds

Transgenic Models

Overexpression studies show [21]:

Anti-inflammatory effects: Reduced inflammation in disease models
Neuroprotection: Protected neurons in injury models
Therapeutic potential: Validates TSG-6 as therapeutic target
Matrix remodeling: Enhanced tissue repair

Therapeutic Models

TSG-6 administration studies demonstrate [22]:

Recombinant protein: Protective in stroke models
Gene therapy: AAV-TSG-6 improves outcomes
Cell therapy: TSG-6-modified stem cells
Combination therapy: Synergistic with other treatments

Genetic Variants

Disease-Associated Polymorphisms

TNFAIP6 genetic variants have been associated with [23]:

Inflammatory diseases: Rheumatoid arthritis, osteoarthritis
Autoimmune conditions: Lupus, IBD
Neurological disorders: Potential MS associations

Variant Functional Effects

| Variant Type | Effect | Disease Association |
|--------------|--------|---------------------|
| Missense | Altered HA binding | Variable |
| Promoter variants | Altered expression | Inflammatory disease |
| 3' UTR variants | Altered mRNA stability | Modified risk |

Therapeutic Implications

Targeting Strategies

Several approaches to modulate TSG-6 for therapeutic benefit are under investigation [24]:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Recombinant protein | Deliver TSG-6 | Preclinical |
| Gene therapy | Deliver TNFAIP6 gene | Early trials |
| Small molecules | Enhance expression | Discovery |
| Cell therapy | TSG-6-modified cells | Early research |

Challenges

Therapeutic targeting of TSG-6 faces significant challenges [25]:

Secreted protein: Requires delivery to target tissues

BBB penetration: CNS delivery challenging

Short half-life: Protein therapeutics limitations

Specificity: Off-target effects must be avoided

Dosing: Optimal dosing regimens not established

Biomarker Potential

TSG-6 as a biomarker [26]:

Disease activity: Correlates with inflammatory markers
Prognostic indicator: Predicts outcomes in some conditions
Therapeutic monitoring: Response to anti-inflammatory treatments

Research Directions

Key Questions

What are the precise mechanisms of TSG-6 neuroprotection?

Can TSG-6 be safely enhanced therapeutically in the CNS?

How do TNFAIP6 variants affect disease risk and progression?

What determines TSG-6's context-specific functions?

Emerging Areas

Structural biology: TSG-6-HA complex structure
Gene editing: CRISPR approaches to modulate TNFAIP6
Biomaterials: TSG-6 as therapeutic in tissue engineering
Systems biology: Network-level understanding

TNFAIP Family Members

| Feature | TNFAIP6 (TSG-6) | TNFAIP3 (A20) | TNFAIP1 (BAP1) |
|---------|---------------|---------------|----------------|
| Function | HA binding, anti-inflammatory | DUB + E3 ligase | DUB + tumor suppressor |
| Localization | Extracellular/secreted | Cytoplasmic | Nuclear |
| Primary role | Matrix remodeling | Inflammation | DNA damage |
| Expression | Inducible | Inducible | Constitutive |

Clinical Considerations

Diagnostic Applications

TSG-6 expression analysis may be useful for [27]:

Disease activity monitoring in neuroinflammatory conditions
Prognostic assessment in brain injury
Therapeutic response prediction

Clinical Trials

No current clinical trials specifically targeting TNFAIP6 in neurodegeneration, but:

Recombinant TSG-6 in inflammatory conditions
Gene therapy trials in related diseases
Cell therapy approaches in development

Summary

TNFAIP6/TSG-6 represents a unique anti-inflammatory protein with important roles in extracellular matrix organization and neuroinflammation control. Its ability to bind hyaluronan and modulate inflammatory responses makes it relevant to neurodegenerative diseases and brain injury. Understanding and targeting TSG-6 offers therapeutic opportunities for conditions characterized by excessive neuroinflammation.

External Links

[NCBI Gene: TNFAIP6](https://www.ncbi.nlm.nih.gov/gene/7132)
[UniProt: TNFAIP6](https://www.uniprot.org/uniprot/P20742)
[Ensembl: TNFAIP6](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000123607)
[OMIM: TNFAIP6](https://www.omim.org/entry/191163)

References

[Milner CM, et al, TSG-6: a multifunctional protein associated with inflammation (2006)](https://doi.org/10.1242/jcs.02750)

[Day AJ, et al, TSG-6 and hyaluronan: key roles in inflammation and immunity (2004)](https://doi.org/10.1002/0470021234.ch9)

[Wislowska M, et al, TSG-6 in inflammatory diseases of the central nervous system (2009)](https://doi.org/10.1016/j.jneuroim.2009.02.014)

[Barcolni S, et al, TSG-6 expression in astrocytes and its neuroprotective role (2020)](https://doi.org/10.1002/glia.23756)

[Sohrabi Y, et al, TSG-6 modulates neuroinflammation in Alzheimer's disease (2021)](https://doi.org/10.1186/s12974-021-02125-x)

[Fritz JH, et al, Acquisition of human TSG-6 by mast cells (2010)](https://doi.org/10.4049/jimmunol.0903130)

[Maine GN, et al, TSG-6 as a biomarker for inflammatory CNS disorders (2012)](https://doi.org/10.3109/1354750X.2012.669384)

[Cheng S, et al, TSG-6 and matrix remodeling in brain injury (2018)](https://doi.org/10.3389/fnmol.2018.00123)

[Kelley KA, et al, TSG-6 promotes neuronal survival after stroke (2014)](https://doi.org/10.1016/j.nbd.2014.04.019)

[Jiang D, et al, TSG-6 variants and susceptibility to inflammatory diseases (2020)](https://doi.org/10.3389/fimmu.2020.00345)

Pathway Diagram

The following diagram shows the key molecular relationships involving tnfaip6 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

TNFAIP6

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tnfaip6
kg_node_id	TNFAIP6
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-3e109bac90f8
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tnfaip6'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)

TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)

Overview

TNFAIP6 — TNF Alpha Induced Protein 6 (TSG-6)

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Post-Translational Processing

Biological Function

Hyaluronan Binding and ECM Organization

Anti-Inflammatory Properties

Cell Adhesion Modulation

Immune Cell Regulation

Expression Pattern

Tissue Distribution

Cellular Localization in the Brain

Regulatory Mechanisms

Role in Neurodegenerative Diseases

Alzheimer's Disease

Multiple Sclerosis

Brain Injury and Stroke

Neuroinflammation

Interaction Network

Protein Interactions

Signaling Pathways

Animal Models

Knockout Studies

Transgenic Models

Therapeutic Models

Genetic Variants

Disease-Associated Polymorphisms

Variant Functional Effects

Therapeutic Implications

Targeting Strategies

Challenges

Biomarker Potential

Research Directions

Key Questions

Emerging Areas

Comparison with Related Genes

TNFAIP Family Members

Clinical Considerations

Diagnostic Applications

Clinical Trials

Summary

See Also

External Links

References

Pathway Diagram

Pathway Diagram

💬 Discussion